|

Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer

RECRUITINGSponsored by Instituto Nacional de Cancerologia de Mexico
Actively Recruiting
SponsorInstituto Nacional de Cancerologia de Mexico
Started2023-06-23
Est. completion2026-06-23
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The goal of this non experimental, transversal instrument study is to Construct and determine the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer in Mexican patients with a lung cancer diagnosis. The main question it aims to answer is: What is the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer of the patients with this diagnosis that are currently undergoing an assessment or follow up program of Respiratory Rehabilitation? The Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC) will be psychometrically valid and reliable for the evaluation of therapeutic adherence on patients with lung cancer that are undergoing an assessment or follow up of Respiratory Rehabilitation.Participants will be asked to fill out an Identification card and fill out the fifty-six items presented on the STA-RR-LC.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients diagnosed with lung cancer (SCLC and NSCLC).
* Over 18 years of age.
* Voluntary participation by understanding and accepting the informed consent letter.
* Patients undergoing Respiratory Rehabilitation treatment with one month assessment and follow-up.
* Patients in active medical treatment.
* Any clinical stage.
* Karnofsky Index ≥ 70.

Exclusion Criteria:

* Severe hearing or visual problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the clinical record file).
* Severe psychiatric conditions (schizophrenia or psychotic disorders) and/or addiction to any psychoactive substance (this will be identified as reported in the INCanet file).
* Attentional or memory problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the INCanet file).

Conditions2

CancerLung Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.